Goose Technologies, a provider of real time performance, compliance and risk management solutions, announced the availability of Procon 2.0, a new risk and compliance management solution specifically designed for the pharmaceutical industry.
The company has signed up with Strides Arcolab, one of India?s leading integrated manufacturers and exporter of finished pharmaceutical dosage forms – both branded and generic, as its customer.
Globally, there is a growing demand for solutions that can tackle compliance procedures and help monitor and ensure pharmaceutical compliance. Procon 2.0 is designed and developed to provide real time visibility of all defined performance, compliance and risk indicators covering myriad operations such as R&D, production, sales, finance, etc for the pharmaceutical organizations.
The all new built in trending engine offers predictability of performance and risk at all user configured business entities apart from providing aggregated views of performance, compliance and risk at all levels of processes and corporate functions.
In addition to these features, Procon offers real time compliance management report in areas of legal, regulatory and quality.
According to Debashish Pattnaik, CEO, Goose Technologies, Procon has evolved from a true real time performance tool to a comprehensive performance, compliance and risk management solution which offers a single view to each and every stakeholder.
With our new industry specific solution, Pharmaceutical firms will be able to bring high degree of efficiency in real time management of performance, compliance and risk in areas of manufacturing, quality, delivery and budget among other important aspects of business process.? Incidentally, Strides Arcolab is going live with Procon, Debashish added.